| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:522985678:1153 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:522985678:1153?format=raw |
LEADER: 01153cam a2200289 a 4500
001 3964962
005 20221027011129.0
008 920407t19891989enka b 000 0 eng d
035 $a(OCoLC)22571532
035 $a(OCoLC)ocm22571532
035 $a(CStRLIN)NYCM92-B2761
035 $9AGA4895HS
035 $a(NNC)3964962
035 $a3964962
040 $aNNC-M$cNNC-M
245 02 $aA critical assessment of cancer chemotherapy /$cguest editor, A.H. Calvert.
260 $aOxford, U.K. :$bPublished for the Imperial Cancer Research Fund by Oxford University Press,$c[1989], ©1989.
300 $apages [493]-708 :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCancer surveys ;$vv. 8, no. 3
504 $aIncludes bibliographical references.
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
710 2 $aImperial Cancer Research Fund (Great Britain)$0http://id.loc.gov/authorities/names/n82160643
700 1 $aCalvert, A. Hilary.$0http://id.loc.gov/authorities/names/n84024237
830 0 $aCancer surveys ;$vv. 8, no. 3.
852 80 $boff,hsr$hSerial$iC